Canada markets close in 1 hour 3 minutes

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.4150+0.0050 (+0.35%)
As of 02:41PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.4100
Open1.4300
Bid1.4100 x 1000
Ask1.4200 x 900
Day's Range1.3600 - 1.4300
52 Week Range0.6500 - 1.5400
Volume117,756
Avg. Volume195,819
Market Cap105.73M
Beta (5Y Monthly)2.31
PE Ratio (TTM)N/A
EPS (TTM)-0.6100
Earnings DateMar 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.67
  • GlobeNewswire

    Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

    ALPHARETTA, Ga., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its fourth quarter and full year 2023 financial results will be reported on Tuesday, March 12, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provi

  • Simply Wall St.

    Pleasing Signs As A Number Of Insiders Buy Clearside Biomedical Stock

    When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

  • GlobeNewswire

    Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

    ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that it has entered into a securities purchase agreement with institutional investors and an existing stockholder, providing for the purchase and sale of 11,111,111 shares of common stock and accompanying warrant to purchase